DUBLIN–(BUSINESS WIRE)–The “Biophotonics Global Market Report 2022, By Product Technology, By Application, By End Use” report has been added to ResearchAndMarkets.com’s offering.

The global biophotonics market is expected to grow from $60.45 billion in 2021 to $67.04 billion in 2022 at a compound annual growth rate (CAGR) of 10.9%. The market is expected to reach $101.57 billion in 2026 at a CAGR of 10.9%.

Major players in the biophotonics market are Thermo Fisher Scientific, OPGEN, NU Skin Enterprises, IPG Photonics Corp., Idex Corp, Toshiba, Procter & Gamble, Horiba and Precision Photonics Corp.

Where is the largest and fastest growing market for the global biophotonics market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Global Biophotonics Market market global report answers all these questions and many more.

The biophotonics market consists of revenues generated from the sales of biophotonic instruments combining optics, nanotechnology, photonics, and biotechnology. Biophotonics is the combination of photonics and biology and is a multidisciplinary research field embracing all light-based technologies applied to life sciences and medicine. It refers to the use of photonic or optical means to examine, control, and track biological processes at various levels of biology: cellular, tissue, molecular, and organism level.

The main product technologies in biophotonics are in-vitro and in-vivo. In vitro studies examine microorganisms, cells, and biological molecules outside of their natural biological framework. These studies in biology and its subdisciplines are generally done in labware such as test tubes, flasks, Petri dishes, and microtiter plates, and are referred to as test-tube investigations.

The different applications include see-through imaging, inside imaging, spectromolecular, surface imaging, microscopy, light therapy, biosensors, others and are used by various sectors such as diagnostics, therapeutic, tests, others.

The increasing demand for minimally invasive surgeries is contributing to the growth of the biophotonics market. Optical engineering and imaging technologies are playing a vital role in the evolving field of minimally invasive surgeries by enabling to visualize the manipulation of tissue at remote internal sites. Therefore, the surge in the number of minimally invasive surgeries annually worldwide is generating higher revenues for the biophotonics market.

High prices of biophotonic-based devices or instruments are anticipated to limit the growth of the biophotonics market. The price of biophotonics is comparatively higher than that of conventional instruments. They are considered as more complex attributing to the integration of biological units and the generation, manipulation, and detection of light units, thereby rising their price. This will negatively impact the biophotonics market growth.

The launch of new advanced techniques in the field of biotechnology is a major trend shaping the biophotonics market. For instance, a team of scientists at the University of St. Andrews (Scotland) developed a fluorescence microscopy technique that allows imaging of delicate biological samples with low damage in neuroscience and biomedicine.

This low damage optical technique is projected to transform the world of biomedicine during the forthcoming years. Hence, the development of new and advanced techniques is gaining significant popularity in the biophotonics market.

The countries covered in the biophotonics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

Key Topics Covered:

1. Executive Summary

2. Biophotonics Market Characteristics

3. Biophotonics Market Trends And Strategies

4. Impact Of COVID-19 On Biophotonics

5. Biophotonics Market Size And Growth

5.1. Global Biophotonics Historic Market, 2016-2021, $ Billion

5.1.1. Drivers Of The Market

5.1.2. Restraints On The Market

5.2. Global Biophotonics Forecast Market, 2021-2026F, 2031F, $ Billion

5.2.1. Drivers Of The Market

5.2.2. Restraints On the Market

6. Biophotonics Market Segmentation

6.1. Global Biophotonics Market, Segmentation By Product Technology, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • In-Vitro
  • In-Vivo

6.2. Global Biophotonics Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • See-Through Imaging
  • Inside Imaging
  • Spectromolecular
  • Surface Imaging
  • Microscopy
  • Light Therapy
  • Biosensors
  • Others

6.3. Global Biophotonics Market, Segmentation By End Use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

  • Diagnostics
  • Therapeutic
  • Tests
  • Others

7. Biophotonics Market Regional And Country Analysis

7.1. Global Biophotonics Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

7.2. Global Biophotonics Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Companies Mentioned

  • Thermo Fisher Scientific
  • NU Skin Enterprises
  • IPG Photonics Corp.
  • Idex Corp.
  • Toshiba
  • Procter & Gamble
  • Horiba
  • Precision Photonics Corp.
  • Roche Group
  • GE
  • Philips
  • Affymetrix Inc.
  • Andor Technology Ltd.
  • Becton Dickinson & Co.
  • Carl Zeiss AG
  • FEI Company
  • Hamamatsu Photonics K.K.
  • Lumenis Ltd.
  • Olympus Corporation
  • PerkinElmer Inc.
  • Zecotek Photonics Inc.
  • Zenalux Biomedical Inc.
  • Glenbrook Technologies Inc.
  • Oxford Instruments Plc

For more information about this report visit https://www.researchandmarkets.com/r/bcj9kz



Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900